TherapeuticsMD Inc Cash Flow-to-Debt Ratio
TherapeuticsMD Inc cash flow-to-debt ratio. TherapeuticsMD Inc (TXMD) has a Cash Flow-to-Debt Ratio of 0.13x as of December 2025, meaning its operating cash flow of $1.37 Million could theoretically repay 0% of its total liabilities ($10.78 Million) in one year. Check TXMD cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of TherapeuticsMD Inc (1994–2025)
Cash flow-to-debt ratio of TherapeuticsMD Inc from 1994 to 2025. Historical debt coverage capacity for TherapeuticsMD Inc across 32 annual periods. Check TherapeuticsMD Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
TherapeuticsMD Inc Cash Flow-to-Debt Ratio by Year (1994–2025)
TherapeuticsMD Inc cash flow-to-debt ratio by year from 1994 to 2025. Year-by-year debt coverage analysis for TherapeuticsMD Inc. For the full cash flow conversion analysis, see TherapeuticsMD Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | $2.45 Million | $10.78 Million | ▲ +256.1% |
| 2024 | 0.06x | $732.00K | $11.45 Million | ▲ +101.9% |
| 2023 | -3.43x | $-48.14 Million | $14.02 Million | ▼ -4556.9% |
| 2022 | -0.07x | $-4.08 Million | $55.31 Million | ▲ +86.9% |
| 2021 | -0.56x | $-147.81 Million | $263.09 Million | ▼ -7.7% |
| 2020 | -0.52x | $-159.47 Million | $305.61 Million | ▲ +19.1% |
| 2019 | -0.65x | $-165.70 Million | $256.78 Million | ▲ +30.9% |
| 2018 | -0.93x | $-106.81 Million | $114.46 Million | ▲ +83.7% |
| 2017 | -5.72x | $-76.16 Million | $13.32 Million | ▼ -23.9% |
| 2016 | -4.61x | $-69.14 Million | $14.98 Million | ▲ +37.7% |
| 2015 | -7.41x | $-79.04 Million | $10.67 Million | ▼ -74.0% |
| 2014 | -4.26x | $-45.52 Million | $10.69 Million | ▼ -50.0% |
| 2013 | -2.84x | $-20.77 Million | $7.32 Million | ▼ -61.6% |
| 2012 | -1.76x | $-12.74 Million | $7.25 Million | ▼ -11.4% |
| 2011 | -1.58x | $-4.97 Million | $3.15 Million | ▼ -359.0% |
| 2010 | 0.61x | $836.83K | $1.37 Million | ▲ +269.3% |
| 2009 | -0.36x | $-417.34K | $1.16 Million | ▲ +90.3% |
| 2008 | -3.72x | $-133.00K | $35.72K | ▼ -184.2% |
| 2007 | 4.42x | $344.10K | $77.83K | ▲ +141.0% |
| 2006 | 1.83x | $329.84K | $179.83K | ▲ +119.4% |
| 2005 | 0.84x | $412.34K | $493.18K | ▼ -85.1% |
| 2004 | 5.60x | $207.73K | $37.12K | ▲ +28.4% |
| 2003 | 4.36x | $140.00K | $32.11K | ▼ -26.8% |
| 2002 | 5.96x | $100.08K | $16.80K | ▼ -15.3% |
| 2001 | 7.03x | $161.95K | $23.04K | ▼ -15.0% |
| 2000 | 8.27x | $133.97K | $16.21K | ▲ +203.3% |
| 1999 | 2.73x | $48.53K | $17.81K | ▲ +210.0% |
| 1998 | 0.88x | $44.60K | $50.72K | ▼ -92.1% |
| 1997 | 11.10x | $77.53K | $6.98K | ▼ -8.9% |
| 1996 | 12.19x | $58.78K | $4.82K | ▲ +1138.6% |
| 1995 | 0.98x | $63.45K | $64.49K | ▼ -84.5% |
| 1994 | 6.35x | $72.86K | $11.47K | — |